Close Menu
Home » Gene by Gene Buys Arpeggi in a Deal to Accelerate Genetic Testing, Dx Services

Gene by Gene Buys Arpeggi in a Deal to Accelerate Genetic Testing, Dx Services

Aug 07, 2013
|
staff reporter

NEW YORK (GenomeWeb News) – Consumer DNA testing firm Gene by Gene today announced the acquisition of bioinformatics firm Arpeggi for an undisclosed amount.

The deal, Gene by Gene said, will accelerate "an innovative suite of more affordable genetics testing and diagnostics services available to consumers, researchers, and healthcare providers."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

That Rude Reviewer

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

New FDA Commish Confirmed

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

DNA Screening for Apple Employees

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

Science Studies Describe Role for Microbiome-Derived Immunity, Platform to Develop Flavivirus Vaccines

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.

What's Popular?

In Informatics

  1. Celmatix Sues 23andMe for $100M Alleging Breach of Contract

  2. DNA Storage Architecture Could Be Used to Store Health Records, Develop Self-Replicating Machines

  3. Colorado Center for Personalized Medicine Biobank Begins Returning Participant PGx Results

    Premium

  4. Biotia Raises $2.4M in Seed Financing

  5. Oncology Pharma to Acquire Stake in Diagnomics

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.